NEW MEDICAL DEVICE TESTING
Reliable testing guaranteeing safety and compliance
NEW SERVICE
RSSL launches dedicated dietary supplements testing service
We have a new home on LinkedIn
Quality
Sustainability
Diversity & Inclusion
Community
Awards
Current vacancies
Early careers
Contact Us
Insights & resources
CPD Hours: 2
Online
Our Responsible Person Forum, provides an opportunity for networking, sharing best practice and discussing current issues with practicing RPs and colleagues working in the GDP field. Each month has a defined topic, as follows :
The world of Good Distribution Practice (GDP) has developed significantly over the past few years. There has been an increase in focus from many regulatory agencies including the MHRA. With Brexit still highly on the agenda, the result of the Brexit deal will undoubtedly have an impact on supply chains for pharmaceutical products sourced from the European Union and European Economic Area. The MHRA published guidance last year to clarify and support the pharmaceutical industry and importers in the UK. RSSL recognises that there is a need to do more to assist industry in creating an environment that supports the role and responsibilities of Responsible Persons for GDP, Logistic Managers and other individuals involved in the pharmaceutical supply chain industry.
The webinars provide the opportunity to:
ex VAT
Special offer
We offer a number of discounts and specials offers on our training courses including Group booking, NHS and Seasonal discounts.
Neil Wayman
Neil is a Microbiologist with over 30 years experience in the pharmaceutical industry. Neil Treasurer of the Pharmaceutical Quality Group and actively involved in running the annual MHRA/PQG meeting. In 2012 he moved back to a role as QA Group manager, QP and RP on the license at AstraZeneca’s second largest manufacturing site at Macclesfield in Cheshire with primary responsible for the site QMS, internal and external inspections, licensing, issue management and recall. In 2018 he moved to AstraZeneca Corporate Quality as Global Quality Director primarily responsible as Global Business Process Owner for Complaints.
Tony Orme
Now an independent consultant, Tony had 32 years experience in the regulation of pharmaceuticals with MHRA, with 22 years within the MHRA Inspectorate leading on the most high profile and complex inspections. Tony has been involved in the development of most UK GDP policies and has a deep understanding on the practical application of GDP and the Human Medicines Regulations and the medicines supply chain.
Related course
Responsible Person refresher
A one day refresher course for Responsible Persons (RP) and Deputy RPs that have already attended their initial RP training.